Piramal Healthcare Ltd is in talks to buy U.S.-based contract drug maker Cambridge Major Laboratories for around $200 mn, according to reports.
Reports stated that Indian drug maker is the flagship company of the Ajay Piramal-owned Piramal Group, while Cambridge Major Laboratories makes pharmaceutical intermediates and active pharmaceutical ingredients that are used in drugs.